Daniel Thomson

South Australian Immunogenomics Cancer Institute

Faculty of Health and Medical Sciences


Dr Daniel Thomson is a computational/molecular biologist passionate about applying genomic technology for cancer research and new diagnostic tests. Joining SAIGENCI in 2025, Daniel is using genomic and transcriptomic approaches to understand mechanisms of cancer therapy resistance, in order to develop new bioinformatic tools to predict patient outcomes.

He has held postdoctoral positions at the Garvan Institute, SA Pathology and Flinders University, and has a proven capacity to translate research findings into clinical diagnostic applications, having lead the bioinformatic development and NATA accreditation of multiple genomic tests currently in the clinic. This includes development of variant and fusion-gene calling pipelines for solid and haematological tumours as lead clinical bioinformatician at Monash Pathology, and a polygenic risk score for glaucoma predisposition testing at an Adelaide-based biotech start-up SeonixBio,

With proven expertise in genomic computational biology in research and biotech industry roles, Daniel is highly motivated with strong research background ( 25 research publications, >4000 citations), This includes first author publications in Nature Reviews Genetics, Nucleic Acids Research and Leukaemia.


Connect With Me
External Profiles